Theseus Pharmaceuticals Inc (THRX) Return on Investment ROI from the third quarter of 2023 to third quarter of 2022 and for the year 2023, average high and low, overall ranking from Sep 30 2023 to Sep 30 2022 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Theseus Pharmaceuticals Inc   (NASDAQ: THRX)


Theseus Pharmaceuticals Inc's ROI from its third quarter of 2023 to the third quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Theseus Pharmaceuticals Inc's ROI in the third quarter of 2023?
Theseus Pharmaceuticals Inc recorded a cumulative net loss of $-57 million during 12 months ending in the third quarter of 2023, resulting in a negative return on investment (ROI) of -24.47%.

Within the Healthcare sector 380 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2023 from 2659 to 3530.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter
Y / Y Investment Change TTM -2.08 % 12.99 % 55.67 % 162.56 % 854.89 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 228 237 249 211 222
Return On Investment (TTM) -24.47 % -25.15 % -23.89 % -22.27 % -19.28 %
THRX's Overall Ranking # 3530 # 2659 # 3561 # 3550 # 0
Seq. Investment Change TTM 0.56 % 0.47 % 0.76 % -3.8 % 16.03 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -57 -58 -55 -51 -46

THRX Company Profile >> Back to THRX Roi Comparisons >> See Annual THRX Return On Investment



Return On Investment THRX's Ranking
Within: No.
Industry # 146
Sector # 381
Overall # 3530

Return On Investment Statistics
High Average Low
-10.88 %
-21.6 %
-32.07 %
(Jun 30 2022)   (Sep 30 2021)







Financial Statements
Theseus Pharmaceuticals Inc's III. Quarter Investments $ 228 Millions THRX's Balance sheet
Theseus Pharmaceuticals Inc's III. Quarter Income $ -14 Millions Quarterly THRX's Income Statement
THRX's Income by Division See THRX's Income by Division


THRX Annual Return On Investment (Dec 31 2022)
2022		 (Dec 31 2021)
2021


Total Investments in Millions 211 247 0 0 0
Y / Y Investment Growth -14.53 % - - - -
Net Income in Millions -51 -27 0 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -23.95 % -11.04 % - - -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
THRX's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for THRX's Competitors
Subscribers only: Roi for Theseus Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for THRX's Customers

Other Ratios
THRX's Roa THRX's Inventory Turnover Ratio THRX's Growth Rates THRX's Dividend Statistics
THRX's Profitability Ratios THRX's Asset Turnover Ratio THRX's Dividend Growth
THRX's Roe THRX's Valuation Ratios THRX's Financial Strength Ratios THRX's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2023, within Healthcare Sector ROI

Date modified: 2026-06-22T14:32:36+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.